Several new clinical trials in prostate cancer have started recruiting in recent months. One of the trials is examining the efficacy of an experimental PARP inhibitor called saruparib when added to a next-generation hormonal agent. This article provides an overview of the study and its potential benefits for patients.
Several new clinical trials in prostate cancer have started recruiting in recent months. Maybe one of your patients could benefit from enrolling? Adults with this diagnosis may be interested in a randomized, double-blind, phase 3 study examining whether an experimental poly (ADP-ribose) polymerase (PARP) inhibitor called saruparib can further delay disease progression when added to a next-generation hormonal agent such as abiraterone (Zytiga), darolutamide (Nubeqa), or enzalutamide (Xtandi).
One group of participants will take daily oral doses of saruparib plus physician's choice of a next-generation hormonal agent until disease progression or another reason for stopping therapy. The other group will add a placebo to a next-generation hormonal agent
Clinical Trials Prostate Cancer Saruparib PARP Inhibitor Next-Generation Hormonal Agent
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New Trials in Prostate Cancer: Could Your Patient Benefit?Perhaps one of your patients could benefit from a clinical trial that has recently opened in prostate cancer.
Read more »
Ambient Clinical Documentation: Transforming Conversations into Clinical NotesAmbient clinical documentation technology allows doctors to record conversations with patients and automatically turn them into clinical notes and summaries using AI. This technology aims to reduce doctor's administrative workload and prioritize connections with patients.
Read more »
Modified CAR-T therapy shows promise in early clinical trialsA modified version of CAR-T therapy, used to treat leukemia and lymphoma, was found to be safe in two small clinical trials. More research is needed to determine its long-term effectiveness.
Read more »
Clinically Speaking: Importance of Clinical Trials in Lupus ResearchAnca Askanase, M.D., answers our questions about why clinical trials are so important for treating lupus
Read more »
Baylor Scott & White clinical trial brings new hope to Arlington man, who's now cancer free'We celebrate our wins,' said Kenny Keown. 'I've been blessed through this process,' he said of a Baylor Scott & White Health clinical trial.
Read more »
Ultrasound Plus MRI May Be New Treatment for Prostate CancerPrecisely delivered ultrasound could be an effective treatment for prostate cancer, with high-frequency sound waves heating and killing off cancer cells, a new study says.
Read more »